We found that for BRCA, LIHC, and LUAD, all had a high expression of TAP1 gene for stage 2 carcinomas, indicating that that TAP1 might be present in an increased amount in stage 2 tumor in various cancers. This evidence concerns the gene TAP1 and neoplasm.